Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|January 15, 2013
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responsesIsabel BaraoBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 17, 2003
The immunobiology of natural killer cells and bone marrow allograft rejectionIsabel Barao, William J MurphyJournal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cellsIsabel Barao, Dorothy Hudig, Joao L AscensaoViruses|December 2, 2017
The Interplay between Natural Killer Cells and Human Herpesvirus-6Eva Eliassen, Dario Di Luca, Roberta Rizzo, et al.Cancers|November 3, 2020
IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell TransplantationMaite Alvarez, Cordelia Dunai, Lam T Khuat, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2013
Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantationIsabel Barao, Paul W Wright, Can M Sungur, et al.Blood|December 21, 2011
Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensingKai Sun, Maite Alvarez, Erik Ames, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantationIsabel Barao, Maite Alvarez, Doug Redelman, et al.Blood|March 5, 2010
Hematopoietic progenitor cell regulation by CD4+CD25+ T cellsMaite Urbieta, Isabel Barao, Monica Jones, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responsesWilliam H D Hallett, Erik Ames, Maite Álvarez, et al.Pageof 2